• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol . Comprehensive Immune Profiling Reveals CD56 + Monocytes and CD31 + Endothelial Cells Are Increased in Severe COVID-19 Disease

tetano

Editor, Senior Moderator
J Immunol


. 2022 Jan 5;ji2100830.
doi: 10.4049/jimmunol.2100830. Online ahead of print.
Comprehensive Immune Profiling Reveals CD56 [SUP]+[/SUP] Monocytes and CD31 [SUP]+[/SUP] Endothelial Cells Are Increased in Severe COVID-19 Disease


Taru S Dutt[SUP] 1 [/SUP], Stephanie M LaVergne[SUP] 2 [/SUP], Tracy L Webb[SUP] 3 [/SUP], Bridget A Baxter[SUP] 2 [/SUP], Sophia Stromberg[SUP] 4 [/SUP], Kim McFann[SUP] 5 [/SUP], Kailey Berry[SUP] 6 [/SUP], Madison Tipton[SUP] 7 [/SUP], Omar Alnachoukati[SUP] 5 [/SUP], Linda Zier[SUP] 5 [/SUP], Greg Ebel[SUP] 1 [/SUP], Julie Dunn[SUP] 5 8 [/SUP], Marcela Henao-Tamayo[SUP] 1 [/SUP], Elizabeth P Ryan[SUP] 9 [/SUP]



Affiliations

Abstract

Immune response dysregulation plays a key role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis. In this study, we evaluated immune and endothelial blood cell profiles of patients with coronavirus disease 2019 (COVID-19) to determine critical differences between those with mild, moderate, or severe COVID-19 using spectral flow cytometry. We examined a suite of immune phenotypes, including monocytes, T cells, NK cells, B cells, endothelial cells, and neutrophils, alongside surface and intracellular markers of activation. Our results showed progressive lymphopenia and depletion of T cell subsets (CD3[SUP]+[/SUP], CD4[SUP]+[/SUP], and CD8[SUP]+[/SUP]) in patients with severe disease and a significant increase in the CD56[SUP]+[/SUP]CD14[SUP]+[/SUP]Ki67[SUP]+[/SUP]IFN-γ[SUP]+[/SUP] monocyte population in patients with moderate and severe COVID-19 that has not been previously described. Enhanced circulating endothelial cells (CD45[SUP]-[/SUP]CD31[SUP]+[/SUP]CD34[SUP]+[/SUP]CD146[SUP]+[/SUP]), circulating endothelial progenitors (CD45[SUP]-[/SUP]CD31[SUP]+[/SUP]CD34[SUP]+/-[/SUP]CD146[SUP]-[/SUP]), and neutrophils (CD11b[SUP]+[/SUP]CD66b[SUP]+[/SUP]) were coevaluated for COVID-19 severity. Spearman correlation analysis demonstrated the synergism among age, obesity, and hypertension with upregulated CD56[SUP]+[/SUP] monocytes, endothelial cells, and decreased T cells that lead to severe outcomes of SARS-CoV-2 infection. Circulating monocytes and endothelial cells may represent important cellular markers for monitoring postacute sequelae and impacts of SARS-CoV-2 infection during convalescence and for their role in immune host defense in high-risk adults after vaccination.
 
Back
Top Bottom